Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$525.28 USD

525.28
842,078

-0.66 (-0.13%)

Updated Nov 5, 2024 04:00 PM ET

After-Market: $525.55 +0.27 (0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Dental Supplies

Zacks News

Sanghamitra Saha headshot

S&P 500 Up 1000 Points in a Month: 10 Stocks Boosted the ETF

The S&P 500 touched the 3,300 mark on Jan 16, having added 1000 points in less than a month. Which stocks led to the ETF rally.

Sweta Killa headshot

10 Top-Ranked S&P 500 Stocks Outperforming in 2020

The rally has been broad based and there are winners across various corners of the space.

Is McKesson (MCK) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

The Zacks Analyst Blog Highlights: Estee Lauder, Bank of New York ??? Mellon, Canadian Pacific Railway, McKesson and Ameriprise Financial

The Zacks Analyst Blog Highlights: Estee Lauder, Bank of New York ??? Mellon, Canadian Pacific Railway, McKesson and Ameriprise Financial

Mark Vickery headshot

Top Stock Reports for Estee Lauder, BNY Mellon & Canadian Pacific Railway

Today's Research Daily features new research reports on 16 major stocks, including Estee Lauder (EL), Bank of New York Mellon (BK) and Canadian Pacific Railway (CP).

MCK vs. ALGN: Which Stock Is the Better Value Option?

MCK vs. ALGN: Which Stock Is the Better Value Option?

McKesson, Walgreens Form JV for European Pharmaceutical Unit

The VA selects McKesson (MCK) as their prime pharmaceutical supplier.

Sreyoshi Mukherjee headshot

SaMD Drives All Facets of US Healthcare: 3 Stocks to Watch

As IoT slowly takes over the healthcare fraternity, let's take a look at three stocks which might prove to be profitable investment options over the long run.

Kinjel Shah headshot

Fed Reportedly Opens Criminal Investigation on Opioid Makers

Shares of some manufacturers and distributors of opioid drugs decline on Tuesday following reports that a criminal probe has been initiated by federal prosecutors.

Here's Why You Should Retain McKesson (MCK) Stock for Now

McKesson (MCK) is gaining from strong segmental performance and solid prospects in the pharmaceutical and medical supplies distribution market. However, rising pricing pressure remains a concern.

McKesson (MCK) Q2 Earnings Meet Estimates, Revenues Beat

McKesson's (MCK) Q2 results gain from higher revenues and solid show by U.S. Pharmaceutical and Specialty, and Medical-Surgical Solutions.

McKesson (MCK) Q2 Earnings Meet Estimates

McKesson (MCK) delivered earnings and revenue surprises of 0.00% and 4.88%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Medical Products' Oct 30 Earnings Roster: MCK, MASI & More

Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have driven the performance of the players in the medical products space this earnings season.

Is McKesson (MCK) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

ResMed's (RMD) Q1 Earnings Beat Estimates, Margins Expand

ResMed (RMD) registers growth at CER across its key operating segments in Q1.

Integra LifeSciences' (IART) Earnings Top Estimates in Q3

We are upbeat about the year-over-year revenue growth in Integra LifeSciences' (IART) Codman Specialty Surgical segment.

Tirthankar Chakraborty headshot

New Strong Buy Stocks for October 25th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday:

Edwards Lifesciences (EW) Beats on Q3 Earnings, Ups EPS View

Edwards Lifesciences (EW) reports strong Q3 sales on the recent FDA indication expansion of SAPIEN 3 and SAPIEN 3 Ultra systems.

Varian (VAR) Earnings and Revenues Surpass Estimates in Q4

Varian (VAR) gains from core Oncology segment's solid contribution in fiscal Q4.

McKesson (MCK) to Report Q2 Earnings: What's in the Offing?

McKesson's (MCK) Pharmaceutical and Specialty Solutions unit is expected to have driven its fiscal Q2 results.

Align Technology (ALGN) Beats on Q3 Earnings, Margins Fall

We are upbeat about Align Technology (ALGN) witnessing continued momentum in Invisalign volumes across all geographies

Boston Scientific (BSX) Beats on Q3 Earnings, Tapers EPS View

Boston Scientific (BSX) is making an all-out effort to solidify its core businesses and invest in the new technologies as well as the global markets. This reflects on the sales uptick in Q3.

Thermo Fisher (TMO) Beats on Q3 Earnings, Lifts Guidance

We are encouraged that three out of Thermo Fisher's (TMO) four business segments have registered strong year-over-year revenue growth in Q3.

Quest Diagnostics (DGX) Q3 Earnings Surpass, View Strong

We are upbeat about Quest Diagnostics' (DGX) expanded network access, which assists the company to accelerate volume growth in Q3.

Cerner's (CERN) AbleVets Buyout to Boost Federal Services

Cerner (CERN) expects to close the AbleVets deal in the fourth quarter of 2019.